Diabetes Connections | Type 1 Diabetes cover art

Diabetes Connections | Type 1 Diabetes

Diabetes Connections | Type 1 Diabetes

By: Stacey Simms
Listen for free

The T1D news show you've been waiting for! Long-time broadcaster, blogger and diabetes mom Stacey Simms interviews prominent advocates, authors and speakers. Stacey asks hard questions of healthcare companies and tech developers and brings on "everyday' people living with type 1. Great for parents of T1D kids, adults with type 1 and anyone who loves a person with diabetes.Stacey Simms Media 2015-2026 Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • 800 Episodes Later: What I've Learned From the Diabetes Community

    800 Episodes Later: What I've Learned From the Diabetes Community
    Jul 7 2026
    We're celebrating 800 episodes of your stories. News, interviews, information, community and much more. To celebrate, we're doing something a little different. Instead of interviewing a guest, Stacey is in the hot seat as podcast producer and friend Jon Gay asks questions submitted by listeners, community members, and some familiar voices from the diabetes world. Stacey looks back on how the podcast started, the moments that shaped it, and the biggest changes she's seen in diabetes technology and care over the last decade. She shares stories from behind the scenes, talks about raising Benny from toddler diagnosis to independent adulthood, and reflects on what continues to inspire her about this community. Along the way, you'll hear about: The breakthroughs that have made the biggest difference for people with diabetesWhat it's really like to cover diabetes news week after weekThe guests she'd still love to interviewThe topics that spark the most passionate debateHow the diabetes community continues to show up for one another Most of all, this episode is a thank you. Whether you've been listening since Episode 1 or just found the show last week, thank you for being part of Diabetes Connections. This community has made 800 episodes possible, and Stacey is grateful for every conversation, every question, and every listener along the way. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com
    Show More Show Less
    59 mins
  • In the News... Tzield, Retatrutide, New Clues About Type 1 and more!

    In the News... Tzield, Retatrutide, New Clues About Type 1 and more!
    Jun 30 2026
    It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Transcript & links: Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's ...
    Show More Show Less
    15 mins
  • Inside Diabetes Will's Way: Helping Families Afford the Care They Need

    Inside Diabetes Will's Way: Helping Families Afford the Care They Need
    Jun 23 2026

    What if I told you that there's a diabetes organization that will write a check to help a family pay for the supplies they need right now. Diabetes Will Way helps families afford insulin pumps, CGMs, and other diabetes technology when insurance falls short. I'm talking to Will Oberndorfer, the company's namesake, as he takes over running the non profit from his mother and godmother, who founded it more than a decade ago.

    We talk about the growing number of young adults struggling to pay for care, why some families are considering going without insurance altogether, and the surprising trends his organization is seeing from the front lines of diabetes affordability.

    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

    Our previous episode with Lisa Oberndorfer click here

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    29 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet